مقالات

 

Combinatorial Treatment Using Umbilical Cord Perivascular Cells and Aβ Clearance Rescues Vascular Function Following Transient Hypertension in a Rat Model of Alzheimer Disease

Paolo Bazzigaluppi,* Tina L. Beckett,* Margaret M. Koletar, Mary E. Hill, Aaron Lai, Arunachala Trivedi, Lynsie Thomason, Adrienne Dorr, Denis Gallagher, Clifford L. Librach, Illsung L. Joo, JoAnne McLaurin, Bojana Stefanovic





  This Article
 

  DOI/PMID:10.1161/HYPERTENSIONAHA.119.13187
  Full Text Paper
  Google Cite
  Google Search
Abstract:

—Transient hypertension is a risk factor for Alzheimer disease (AD), but the effects of this interaction on brain vasculature are understudied. Addressing vascular pathology is a promising avenue to potentiate the efficacy of treatments for AD. We used arterial spin labeling magnetic resonance imaging to longitudinally assess brain vascular function and immunohistopathology to examine cerebrovascular remodeling and amyloid load. Hypertension was induced for 1 month by administration of l-NG-nitroarginine-methyl-ester in TgF344-AD rats at the prodromal stage. Following hypertension, nontransgenic rats showed transient cerebrovascular changes, whereas TgF344-AD animals exhibited sustained alterations in cerebrovascular function. Human umbilical cord perivascular cells in combination with scyllo-inositol, an inhibitor of Aβ oligomerization, resulted in normalization of hippocampal vascular function and remodeling, in contrast to either treatment alone. Prodromal stage hypertension exacerbates latter AD pathology, and the combination of human umbilical cord perivascular cells with amyloid clearance promotes cerebrovascular functional recovery. (Hypertension. 2019;74:1041-1051. DOI: 10.1161/HYPERTENSIONAHA.119.13187.)


keywords: Alzheimer disease,hypertension,inositol,risk factor,umbilical cord